Patents by Inventor Stefanie Decker

Stefanie Decker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE
    Publication number: 20250255936
    Abstract: A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing IGP-1, and treating conditions associated with carcinoid tumors and VIPomas by administering a controlled release formulation of octreotide are provided herein.
    Type: Application
    Filed: January 10, 2025
    Publication date: August 14, 2025
    Applicant: Endo Operations Limited
    Inventors: Petr Kuzma, Stefanie Decker
  • DELIVERY OF DRY FORMULATIONS OF OCTREOTIDE
    Publication number: 20250249067
    Abstract: Methods and devices are described for delivering octreotide to a patient, comprising implanting a controlled release composition for delivering octreotide, wherein the composition does not require hydration prior to implantation, and wherein the composition optionally comprises a release agent.
    Type: Application
    Filed: January 10, 2025
    Publication date: August 7, 2025
    Applicant: Endo Operations Limited
    Inventors: Petr Kuzma, Stefanie Decker
  • CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE
    Publication number: 20200046806
    Abstract: A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid tumors and VIPomas by administering a controlled release formulation of octreotide are provided herein.
    Type: Application
    Filed: August 22, 2019
    Publication date: February 13, 2020
    Applicant: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Stefanie Decker
  • CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE
    Publication number: 20170100461
    Abstract: A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid tumors and VIPomas by administering a controlled release formulation of octreotide are provided herein.
    Type: Application
    Filed: August 24, 2016
    Publication date: April 13, 2017
    Applicant: ENDO PHARMACEUTICALS SOLUTIONS INC.
    Inventors: Petr Kuzma, Stefanie Decker
  • DELIVERY OF DRY FORMULATIONS OF OCTREOTIDE
    Publication number: 20170049850
    Abstract: Methods and devices are described for delivering octreotide to a patient, comprising implanting a controlled release composition for delivering octreotide, wherein the composition does not require hydration prior to implantation, and wherein the composition optionally comprises a release agent.
    Type: Application
    Filed: August 24, 2016
    Publication date: February 23, 2017
    Applicant: ENDO PHARMACEUTICALS SOLUTIONS INC.
    Inventors: PETR KUZMA, STEFANIE DECKER
  • Method of manufacturing an implantable device
    Patent number: 9072786
    Abstract: Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: July 7, 2015
    Assignee: ENDO PHARMACEUTICALS SOLUTIONS INC.
    Inventors: Petr Kuzma, Stefanie Decker, Harry Quandt
  • SUSTAINED DELIVERY OF EXENATIDE AND OTHER POLYPEPTIDES
    Publication number: 20130252894
    Abstract: Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof.
    Type: Application
    Filed: May 20, 2013
    Publication date: September 26, 2013
    Applicant: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Stefanie Decker, Harry Quandt
  • Method of manufacturing an implantable device
    Patent number: 8475820
    Abstract: Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof.
    Type: Grant
    Filed: July 27, 2010
    Date of Patent: July 2, 2013
    Assignee: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Stefanie Decker, Harry Quandt
  • Octreotide implant having a release agent
    Patent number: 8383577
    Abstract: Methods, formulations and kits are described that allow for the controlled release of octreotide, e.g., octreotide acetate, in a subject.
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: February 26, 2013
    Assignee: Endo Pharmaceuticals Solutions, Inc.
    Inventors: Petr Kuzma, Stefanie Decker, Harry Quandt
  • Implantable device for the sustained release of a polypeptide
    Patent number: 8071537
    Abstract: Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof.
    Type: Grant
    Filed: June 24, 2009
    Date of Patent: December 6, 2011
    Assignee: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Stefanie Decker, Harry Quandt
  • OCTREOTIDE IMPLANT HAVING A RELEASE AGENT
    Publication number: 20110206745
    Abstract: Methods, formulations and kits are described that allow for the controlled release of octreotide, e.g., octreotide acetate, in a subject.
    Type: Application
    Filed: April 29, 2011
    Publication date: August 25, 2011
    Inventors: Petr KUZMA, Stefanie Decker, Harry Quandt
  • Octreotide implant having a release agent and uses thereof
    Patent number: 7960335
    Abstract: Methods, formulations and kits are described that allow for the controlled release of octreotide, e.g., octreotide acetate, in a subject.
    Type: Grant
    Filed: June 24, 2009
    Date of Patent: June 14, 2011
    Assignee: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Stefanie Decker, Harry Quandt
  • CONTROLLED RELEASE FORMULATIONS OF OCTREOTIDE
    Publication number: 20110009338
    Abstract: A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid tumors and VIPomas by administering a controlled release formulation of octreotide are provided herein.
    Type: Application
    Filed: June 11, 2010
    Publication date: January 13, 2011
    Inventors: Petr KUZMA, Stefanie Decker
  • SUSTAINED DELIVERY OF EXENATIDE AND OTHER PEPTIDES
    Publication number: 20100292144
    Abstract: Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof.
    Type: Application
    Filed: July 27, 2010
    Publication date: November 18, 2010
    Inventors: Petr KUZMA, Stefanie Decker, Harry Quandt
  • DELIVERY OF DRY FORMULATIONS OF OCTREOTIDE
    Publication number: 20100247594
    Abstract: Methods and devices are described for delivering octreotide to a patient, comprising implanting a controlled release composition for delivering octreotide, wherein the composition does not require hydration prior to implantation, and wherein the composition optionally comprises a release agent.
    Type: Application
    Filed: June 11, 2010
    Publication date: September 30, 2010
    Inventors: Petr KUZMA, Stefanie Decker
  • Controlled release formulations of octreotide
    Patent number: 7803773
    Abstract: A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid tumors and VIPomas by administering a controlled release formulation of octreotide are provided herein.
    Type: Grant
    Filed: September 29, 2008
    Date of Patent: September 28, 2010
    Assignee: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Stefanie Decker
  • Delivery of dry formulations of octreotide
    Patent number: 7759312
    Abstract: Methods and devices are described for delivering octreotide to a patient, comprising implanting a controlled release composition for delivering octreotide, wherein the composition does not require hydration prior to implantation, and wherein the composition optionally comprises a release agent.
    Type: Grant
    Filed: July 11, 2008
    Date of Patent: July 20, 2010
    Assignee: Endo Pharmaceuticals Solutions Inc.
    Inventors: Petr Kuzma, Stefanie Decker
  • SUSTAINED DELIVERY OF EXENATIDE AND OTHER PEPTIDES
    Publication number: 20100021522
    Abstract: Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof.
    Type: Application
    Filed: June 24, 2009
    Publication date: January 28, 2010
    Inventors: Petr Kuzma, Stefanie Decker, Harry Quandt
  • OCTREOTIDE IMPLANT HAVING A RELEASE AGENT
    Publication number: 20100022450
    Abstract: Methods, formulations and kits are described that allow for the controlled release of octreotide, e.g., octreotide acetate, in a subject.
    Type: Application
    Filed: June 24, 2009
    Publication date: January 28, 2010
    Inventors: Petr KUZMA, Stefanie Decker, Harry Quandt
  • DELIVERY OF DRY FORMULATIONS OF OCTREOTIDE
    Publication number: 20090035343
    Abstract: Methods and devices are described for delivering octreotide to a patient, comprising implanting a controlled release composition for delivering octreotide, wherein the composition does not require hydration prior to implantation, and wherein the composition optionally comprises a release agent.
    Type: Application
    Filed: July 11, 2008
    Publication date: February 5, 2009
    Inventors: Petr KUZMA, Stefanie Decker